#Medicilon will exhibit the ACS Fall 2020 Virtual Meeting & Expo from Aug 17-20. Please visit https://calendly.com/fywang to schedule a 1-on-1 meeting with our VP
On July 20, 2020, DAC Biotech’s new ADC drug development, TROP2-ADC—DAC-002 was approved of clinical study by NMPA. for the indication of solid malignant tumor.
Chuansha, Shanghai, June 29, 2020. — Convalife and Medicilon signed a strategic pact, initiating a long-term cooperation between the two companies. Based on previous cooperation
Heganding comes in 100-mg tablets. It’s a treatment for chronic Heptitis B adult patients with ALT rising, active virus replicating and liver decompensation. During the
